"Médicaments Développement." . . "Essais cliniques des médicaments." . . "Criblage à haut débit (Développement des médicaments)" . . . . "Conception de médicaments." . . "Développement de médicaments." . . "Drugs Testing." . . "Drugs Testing" . "Drug development, Drugs testing." . . . "This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as \"second generation\" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book."@en . . . . "This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as \"second generation\" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book." . "Pharmaceutical Biotechnology for Target Validation" . . . . . "<>" . . "Ressource Internet (Descripteur de forme)" . . . . . . . . . . . . "Target Validation in Drug Discovery"@en . "Target Validation in Drug Discovery" . . . . . . . . . . . . . . "Livre électronique (Descripteur de forme)" . . . . . . . . . "This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics."@en . . "Target Validation for Biopharmaceutical Drug Discovery" . . . "Electronic books"@en . "Electronic books" . . . "Livres électroniques" . . . "Target validation in drug discovery"@en . "Target validation in drug discovery" . . . . "Validating Targets of Small Molecule Approaches" . . "Llibres electrònics" . . . . . . . . . . "Target validation in drug discovery = 药物发现中的靶标确认" . . "Drug Delivery Systems" . . "Drug Delivery Systems." . "Drug delivery systems." . "MEDICAL Nursing Pharmacology." . . "Dispositif d'administration de médicaments." . . "High throughput screening (Drug development)" . . "Conception de médicament." . . "Criblage pharmacologique." . . "Biopharmacie." . . "Médicaments Essais cliniques." . . "ScienceDirect (Service en ligne)" . . "MEDICAL Pharmacology." . . "Drug Design." . . "Drug Design" . "Drug development." . . "Drug development" . "MEDICAL Drug Guides." . . "Cible thérapeutique." . . "Technology, Pharmaceutical" . . "Technology, Pharmaceutical." . "Étude clinique." . . "Médicaments Mise au point." . . "Biopharmaceutics" . . "Biopharmaceutics." . "MEDICAL Pharmacy." . . "Technologie pharmaceutique." . .